pharmaphorum

NOVEMBER 9, 2020

The vaccine is based on a strand of messenger RNA – a short segment of genetical material that codes for the “Spike” protein found on the surface of the coronavirus. These cause the body to produce antibodies that neutralise the SARS-CoV-2 virus in the event of an infection.

Vaccines 98

Vaccines Hospitals FDA 98

pharmaphorum

DECEMBER 16, 2022

The world was caught unprepared for the global pandemic that struck in 2020. The negotiations over the treaty are being hosted through the World Health Organization (WHO), with plans to officially adopt a binding agreement sealed by the United Nations health agency’s member countries in May 2024.

Vaccines 96

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 96

pharmaphorum

MAY 13, 2022

Way back in January 2020, Pfizer’s 2019 annual report could only note the potential disruption from a novel strain of coronavirus. So much was then unknown about it that the only sure thing about the outbreak was the high level of uncertainty about its effects. Looking back now, the rate of change still astounds. About the author.

Pharmaceutical Companies 131

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 131

pharmaphorum

OCTOBER 9, 2020

The agreement is the third for coronavirus vaccine supply for the EU, coming after earlier deals with AstraZeneca and Sanofi/GlaxoSmithKline, and comes as wealthy nations are scrambling to secure access to the initial supplies of the shots furthest ahead in development. Remdesivir procurement.

Vaccines 105

Vaccines 105

pharmaphorum

JUNE 3, 2021

“Oxfordshire’s global role in the scientific response to the Covid-19 pandemic has further strengthened our reputation for establishing and attracting world-leading life sciences businesses and innovators,” says Ahmed Goga, Director of Strategy at the Oxfordshire Local Enterprise Partnership (OxLEP).

Vaccines 52

Vaccines 52

pharmaphorum

NOVEMBER 12, 2020

The phase 3 trial results are a huge advance in the fight against the global coronavirus pandemic. We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis.”.

Vaccines 87

Vaccines FDA 87

pharmaphorum

SEPTEMBER 24, 2020

There is now an expectation that, as well as continuing the work on stemming the impact of the coronavirus, healthcare providers must meet the requirements of what has become known as the Phase Three letter. Pre-outbreak, the waiting list for elective treatments stood at 4.4 Data at the heart of the post-pandemic world.

Data Entry 111

Data Entry Documentation Hospitals 111

pharmaphorum

JANUARY 21, 2021

While restrictions on travel could prevent coronavirus transmission in the short term, digital passports showing COVID-negative and vaccination status may help reopen airports and other badly hit areas of the economy, reports Richard Staines.

Vaccines 85

Vaccines Immunization Hospitals 85

pharmaphorum

DECEMBER 9, 2020

ASCO Coronavirus Resources – FAQs ? I know these guidelines are reasonable, but I am having a hard time deciding which of my cancer patients should continue treatment during #COVID19 outbreak and which can delay treatment for 3 mos. — Aditya Bardia, MD (@ABhealer108) March 14, 2020. HCPs look to the future.

Hospitals 124

Hospitals Clinic Management Pharmaceutical Companies Pharmaceutical Companies 124

European Pharmaceutical Review

AUGUST 10, 2022

On 23 July 2022, the World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus, declared the multi-country outbreak of monkeypox a public health emergency of international concern. Human-to-human transmission is limited and not regarded as sufficient to sustain an outbreak. Current case rates.

Vaccines 71

Vaccines FDA Immunization Labelling 71

pharmaphorum

OCTOBER 18, 2021

Within 12 months of the outbreak, vaccines were being deployed to prevent severe infections, hospitalisation, and death. In many parts of the world, the deployment of COVID-19 vaccines during the pandemic was based, at least in part, on their approval in other countries. Integrating real-world data and real-world evidence.

Vaccines 143

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 143

pharmaphorum

AUGUST 3, 2020

While the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug as an alternative way to prevent viral transmission in high-risk locations. The fleet will be sent out in response to outbreaks of the virus at long-term care units. Results are due before the end of the year.

Nursing Homes 59

Nursing Homes Long-Term Care Facilities Immunization Vaccines 59

pharmaphorum

NOVEMBER 19, 2021

The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic. Furthermore, the firm’s prerogative wasn’t optics, he says, but rather a pricing model that was better for the world.

Vaccines 137

Vaccines Communication 137

pharmaphorum

OCTOBER 21, 2020

Even better I'm doing it with my first team @HarrowNursing BBC News – Coronavirus: Missing school is worse than virus for children [link]. However, the evidence is not conclusive as to whether this was due to COVID-19 outbreaks or fears. School Nurses are around to support our schools when they reopen.

Hospitals 105

Hospitals Communication 105

pharmaphorum

AUGUST 24, 2020

Several Chinese companies have started clinical trials of coronavirus vaccine candidates, and three shots based on inactivated SARS-CoV-2 from Sinovac and Sinopharm are heading for phase 3 testing, according to the World Health Organisation’s latest update on vaccine progress.

Vaccines 69

Vaccines FDA 69